3M expects 2026 organic sales growth of ~3%, accelerating from 2.1%
Guidance tone
3M reported strong FY2025 Q4 results with organic growth of 2.2% and EPS of $1.83, beating guidance. Full-year organic sales grew 2.1% with margin expansion of 200 bps. Management guided FY2026 EPS of $8.50-$8.70 and ~3% organic growth, driven by new product launches and commercial excellence. Notable cross-company signal: Solventum transition service wind-down will reduce 3M's income by $50-75M in 2026. 3M's operational turnaround continues: OTIF above 90%, cost of quality improving, new product launches up 68% YoY.
3M reported strong FY2025 Q4 results with organic growth of 2.2% and EPS of $1.83, beating guidance. Full-year organic sales grew 2.1% with margin expansion of 200 bps. Management guided FY2026 EPS of $8.50-$8.70 and ~3% organic growth, driven by new product launches and commercial excellence. Notable cross-company signal: Solventum transition service wind-down will reduce 3M's income by $50-75M in 2026. 3M's operational turnaround continues: OTIF above 90%, cost of quality improving, new product launches up 68% YoY.
Guidance tone
3M's operational turnaround continues: OTIF above 90%, cost of quality improving, new product launches up 68% YoY.
Guidance for 2026: EPS $8.50-$8.70, organic growth ~3%, margin expansion 70-80 bps, FCF conversion >100%.
Consumer business weakened in Q4 (down 2.2%) but December showed double-digit growth; mgmt expects return to growth in 2026.
Management mentioned using AI-enabled models to optimize changeovers and improve quality, and an AI-first mentality as part of the transformation to an integrated operating company, but AI is not a major revenue driver discussed in this call.
Consumer electronics growth in 2026 expected mid-single digits, expanding into mainstream. Management repeatedly emphasized strong execution, outperforming macro, and momentum into 2026, with forward guidance above 2025 results.
Management did not provide specific capital expenditure guidance, but discussed transformation investments to redesign manufacturing, distribution, and business processes, with a $55 million charge in Q4 and plans to increase growth and productivity investments to $225 million in 2026.
Management repeatedly emphasized strong execution, outperforming macro, and momentum into 2026, with forward guidance above 2025 results.
“OTIF ended the year above 90%, 300 basis points above the prior year and the best we've achieved in decades, and we sustained that rate for seven months in a row.”
“Sales from products launched in the last five years were up 23% in the full year, exceeding our high teens target, and exit Q4 at 44%, giving us momentum into 2026.”
| Показатель | Период | Диапазон | Середина | Статус |
|---|---|---|---|---|
| EPS | FY2026 | $8.50–$8.70 | $8.60 | MAINTAINED |
| Дата прогноза | Показатель | Целевой период | Прогноз | Факт | Результат |
|---|---|---|---|---|---|
| FY2026 Q1 | Revenue | FY2026 Q2 | 3% | 5.4% | Met / beat |
| FY2025 Q3 | EPS | FY2025 | $7.95–$8.05 | $8.06 | Met / beat |
| FY2025 Q3 | Revenue | FY2025 | 2% | 2.1% | Met / beat |
Winding down transition services agreements with Solventum will reduce 3M's corporate income by $50-75 million in 2026, indicating a decreasing dependency but also a potential headwind for 3M's other income.
“Corporate and other income will be lower by $50 to $75 million, or 20 to 30 basis points, largely from wind-down of transition services agreements related to Solventum.”
… million or 100 basis points, including $875 million from volume growth and net productivity across supply chain and G&A. This will be partially offset by headwinds from PFAS stranded costs and tariff impacts, as well as an increase in growth and productivity investments to $225 million. This is on top of the incremental investment over the past two years, bringing the total investment from 2024 to over half a billion dollars. Corporate and other income will be lower by $50 to $75 million, or 20 to 30 basis points, largely from wind-down of transition services agreements related to Solventum. Overall, we expect total company income to grow by $400 million at the midpoint of our 70 to 80 basis points margin expansion guide. Adjusted free cash flow conversion is expected to be greater than 100% driven by strong operating income growth and a focus on working capital management. And we plan to deploy capital effectively, including a gross share repurchase of approximately $2.5 billion in 2026. Slide 11 provides a look at earnings growth drivers, which is primarily driven by strong operations consistent with our 2025 performance. Regarding cadence, we expect the rate of sales growth …